ClinicalTrials.govpublic full text
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
thrombotic microangiopathies, hematopoietic stem cell transplantation, tma, hsct, pediatric, bmt, oms721, narsoplimab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801002
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.